CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
What is Market Cap of Cytodyn Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cytodyn Inc market cap is $367.32M.
What is the 52-week high for Cytodyn Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cytodyn Inc 52 week high is $0.4945 as of September 12, 2025.
What is the 52-week low for Cytodyn Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cytodyn Inc 52 week low is $0.1031 as of September 12, 2025.
What is Cytodyn Inc stock price today?
Cytodyn Inc stock price today is $0.2858.
What was Cytodyn Inc stock price yesterday?
Cytodyn Inc stock price yesterday was $0.2935.
What is the PE ratio of Cytodyn Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cytodyn Inc’s P/E ratio is 127.61.
What is the Price-to-Book ratio of Cytodyn Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cytodyn Inc P/B ratio is -3.8176.
What is the 50-day moving average of Cytodyn Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cytodyn Inc 50-day moving average is $0.2965.